The current review confirmed the performance and safety of curcumenol, but there remain some issues and constraints to our scientific studies. For performance, the systemic distribution of curcumenol following intraperitoneal injection was not assessed, Consequently there was an absence of direct proof which the optimum concentration of curcumenol achieved the https://ml-21046788.pages10.com/little-known-facts-about-rad51-inhibitor-b02-62389283